Funding: Wellcome Trust (London Pain Consortium), Innovative Medicines Initiative – EUROPAIN (European Commission and selected EFPIA members) and Derek Butler Trust.
Recommended reading
[1] Wallace VCJ, et al. Characterisation of rodent models of HIV-gp120 and antiretroviral associated neuropathic pain. Brain 2007;130:2688-702.10.1093/brain/awm195Search in Google Scholar PubMed PubMed Central
[2] Wallace VCJ, et al. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 2007;133:47-63.10.1016/j.pain.2007.02.015Search in Google Scholar PubMed PubMed Central
[3] Maratou K, et al. Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain. European Journal of Pain 2009;13:398.10.1016/j.ejpain.2008.05.011Search in Google Scholar PubMed PubMed Central
[4] Phillips TJC, et al. Painful HIV-associated sensory neuropathy. Pain: Clinical Updates 2010;XVIII:1-8.Search in Google Scholar
[5] Phillips TJC, et al. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS ONE 2010;5:e14433.10.1371/journal.pone.0014433Search in Google Scholar PubMed PubMed Central
© 2012 Scandinavian Association for the Study of Pain
